The impact of patient characteristics and disease-specific factors on first-line treatment decisions for BRAF-mutated melanoma

Treatment decisions for advanced melanoma are increasingly complex and guidelines provide limited advice on how to choose between immunotherapy and targeted therapy for first-line treatment. A Delphi study was carried out to understand which patient characteristics and disease-related factors inform